Pharmaceutical formulation 514

Details for Australian Patent Application No. 2009300866 (hide)

Owner AstraZeneca UK Limited

Inventors Bechtold, Michael Karl; Packhaeuser, Claudia Bettina; Cahill, Julie Kay; Fastnacht, Katja Maren; Liepold, Bernd Harald; Lennon, Kieran James; Steitz, Benedikt

Agent Davies Collison Cave

Pub. Number AU-A-2009300866

PCT Pub. Number WO2010/041051

Priority 61/103,347 07.10.08 US

Filing date 5 October 2009

Wipo publication date 15 April 2010

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

7 April 2011 PCT application entered the National Phase

  PCT publication WO2010/041051 Priority application(s): WO2010/041051

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009300869-Pyridine and pyrimidine based compounds as Wnt signaling pathway inhibitors for the treatment of cancer

2009300862-Flexible pipe having pressure armour layer and components thereof